The Covid-19 pandemic has created a new level of urgency for R&D organizations to move faster and adapt to more complex and high-risk environments with even less margin for error. In this panel, our speakers offer advice on implementing workflow automation to mitigate operational risk and how to continue to invest in the development of advanced solutions while helping teams build sustainable performance goals and operational excellence in the lab.
Making sure data from across the product lifecycle is complete, available and usable is vital for the success of any R&D organization. In this session, we will share lessons on how to integrate a single source of truth for data collection, so companies can optimize innovation and process efficiency to accelerate the manufacture of industry-leading products.
SPEAKER: Dr. Haydn Boehm, Head of Commercial Marketing - Connected Lab at Merck Group
Historically, discovery data has been siloed with limited opportunity for analysis. With the volume and variety of data increasing, storage, management and data integrity are becoming key challenges for the laboratory. This session will share insight on how to transform your data practices, incorporate FAIR from the start and minimize costs.
As technology continues to advance in the lab, it is nearly impossible to shy away from the revolution of artificial intelligence (AI) in scientific research and its utility in the lab space. In this debate roundtable, experts will argue two main trends leveraging AI: automation and augmentation. The experts will deep dive into the benefits of both views and discuss how the pharma industry can profit from digital innovation and prepare for the challenges it brings.
SPEAKERS: Dr. Célia Gasselin, Growth Coordinator at LabTwin
Christos Varsakelis, Team Lead AI/M at The Janssen Pharmaceutical Companies of Johnson & Johnson
Mathew Divine, Senior Data Scientist at Boehringer Ingelheim
The pace of innovation continues to advance, with new tools and solutions continuing to emerge. But what new tech is set to have the biggest impact on the way we work? In this session, we analyze some of the most cutting edge technology on the market to give you insight on what stands out.
Data mining, AI, machine learning and advanced analytics are growing in use across the R&D space, promising new levels of efficiency and augmented scientific capabilities. In this session, we look into the realities of implementing an AI-powered tool in the lab and how companies can proactively prepare for this disruptive technology.
Pharma IQ and Pharma Logistics IQ
Team Lead AI/M
The Janssen Pharmaceutical Companies of Johnson & Johnson
Senior Data Scientist
Head of Commercial Marketing, Digital Lab Productivity Solutions
Associate VP of Chemicals and Materials Marketing
Dennis Della Corte
Chief Science Officer